Reports on drug supply in the americans 2022
Date of Publication
1-1-2022 12:00 AM
Security Theme
Human Rights
Keywords
Drug supply trends, drug trafficking, local agencies, drug landscape, technology, human rights
Description
The "Report on Drug Supply in the Americas 2022" was orchestrated by the Inter-American Drug Abuse Control Commission (CICAD) within the Organization of American States (OAS). The report offers insights on drug supply trends in the Americas, drawing data from 33 OAS member states including nations like Brazil, Canada, Mexico, and the United States. These nations collaborated through the Technical Working Group on Drug Supply Indicators or enabled data access from local agencies, supported by additional qualitative interviews. Key contributors included Tiffany Barry, Daniela Chiriboga, Dr. Carolina Sampo, and Dr. Bryce Pardo. The report aligns with the OAS Hemispheric Drug Strategy 2020, revealing the complexities of the drug problem in the region and emphasizing evidence-based policies. The overarching aim is to provide a comprehensive view of the drug landscape in the Americas, aiding in the formulation of data-driven drug policies. The alarming evolution of the drug trafficking problem, including heightened drug production and potency and the complexities introduced by technology and transnational criminal organizations, underscores the importance of this collaborative report.
Reports on drug supply in the americans 2022
The "Report on Drug Supply in the Americas 2022" was orchestrated by the Inter-American Drug Abuse Control Commission (CICAD) within the Organization of American States (OAS). The report offers insights on drug supply trends in the Americas, drawing data from 33 OAS member states including nations like Brazil, Canada, Mexico, and the United States. These nations collaborated through the Technical Working Group on Drug Supply Indicators or enabled data access from local agencies, supported by additional qualitative interviews. Key contributors included Tiffany Barry, Daniela Chiriboga, Dr. Carolina Sampo, and Dr. Bryce Pardo. The report aligns with the OAS Hemispheric Drug Strategy 2020, revealing the complexities of the drug problem in the region and emphasizing evidence-based policies. The overarching aim is to provide a comprehensive view of the drug landscape in the Americas, aiding in the formulation of data-driven drug policies. The alarming evolution of the drug trafficking problem, including heightened drug production and potency and the complexities introduced by technology and transnational criminal organizations, underscores the importance of this collaborative report.
